Sputnik V Vaccine Approved in India: DGCI has approved Russia's Sputnik V vaccine for emergency use in India. Sputnik V becomes the third vaccine that will be administered to Indians.
Sputnik V Vaccine Approved in India: DGCI has approved Russia's Sputnik V vaccine for emergency use in India. Sputnik V becomes the third vaccine that will be administered to Indians.
Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India (DCGI) for the additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19.
The expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give the third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine.
BJP National Spokesperson Sambit Patra on monday held a press conference at BJP HQ where he hit back at the Congress over the questions raised by congress party over the DGCI's approval of two indegenous vaccines for usage.
Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its COVID-19 vaccine ZyCoV-D.
In a significant development, Drugs Controller General of India (DGCI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin for use in India.
The expert panel has recommended granting permission for restricted emergency use of 'Covaxin' in "public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains.
Drug Controller General of India (DCGI) on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use against coronavirus.
In a significant development, Drugs Controller General of India (DGCI) on Sunday (January 3) formally approved Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin for use in India.
The AIDAN has said it is shocked to learn about the recommendation to grant REU approval to Bharat Biotech's COVAXIN in "clinical trial mode" and "specially in the context of infection by mutant strains".
In a regulatory filing, Zydus Cadila said it has received approval from the DCGI to start the phase 3 clinical trials in COVID-19 patients with its biological therapy Pegylated Interferon alpha-2b or PegiHep.
The Directorate General of Goods and Services Tax Intelligence (DGGI) has found alleged evasion of GST collectively worth over Rs 108 crore by two liquor manufacturers in Aurangabad and Nanded districts of Maharashtra
The Drug Controller General of India (DCGI) issued notices to Glenmark seeking clarification from the company regarding the false claim that its antiviral drug Fabiflu, is effective on COVID-19 patients with co-morbidities.
The executive chairperson of Biocon, Kiran Mazumdar Shaw said, "It is an injection containing 25mg/5mL solution for emergency use in India for the treatment of Cytokine Release distress syndrome (ADRS) patients caused by the COVID-19".
With ZyCoV-D, the Company has successfully established the DNA vaccine platform in the country using non-replicating and non-integrating plasmid carrying the gene of interest making it very safe.
Country's drugs regulator has asked all states and Union Territories to prohibit sale of drugs by online pharmacies as per the Delhi High Court order, a senior health ministry official said on Wednesday. The court while hearing a PIL by Zaheer Ahmed in December 2018 had ordered the ban on sale of illegal or unlicensed online sale of medicines till the government drafts rules to regulate e-pharmacies.
Top News
Latest News
